ÂÜÀòÂÒÂ×

Aimee Smart is the Vice President of Clinical Development & Regulatory Processes at Lung Biotechnology. Ms. Smart brings with her more than two decades of leadership experience in regulatory affairs and drug development along with a wealth of knowledge in creating and implementing strategies with the goal of successful US and international regulatory filings. Prior to Lung Biotechnology, she was the Director of Regulatory Affairs for VIRxSYS Corporation and worked in Regulatory Affairs at Human Genome Sciences, Nabi Biopharmaceuticals, and Cato Research. In her current position, Ms. Smart leads Regulatory and Clinical Research and Development at both Lung Biotechnology and Lung Bioengineering.